 | • レポートコード：MRC23Q36195 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のmRNAプラットフォーム市場について調査・分析し、世界のmRNAプラットフォーム市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（感染症ワクチン、がんワクチン）、用途別セグメント分析（感染症、がん）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Arcturus Therapeutic、Argos Therapeutics、BioNTec、CureVac、Etherna、Ethris、GlaxoSmithKline、Pfizer、Translate Bioなどが含まれています。世界のmRNAプラットフォーム市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、mRNAプラットフォーム市場規模を推定する際に考慮しました。本レポートは、mRNAプラットフォームの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、mRNAプラットフォームに関するビジネス上の意思決定に役立てることを目的としています。 ・mRNAプラットフォーム市場の概要 - mRNAプラットフォームのタイプ別セグメント - 世界のmRNAプラットフォーム市場規模：タイプ別分析（感染症ワクチン、がんワクチン） - mRNAプラットフォームの用途別セグメント - 世界のmRNAプラットフォーム市場規模：用途別分析（感染症、がん） - 世界のmRNAプラットフォーム市場規模予測（2018年-2029年） ・mRNAプラットフォーム市場の成長トレンド - mRNAプラットフォームの地域別市場規模（2018年-2029年） - mRNAプラットフォーム市場ダイナミクス - mRNAプラットフォームの業界動向 - mRNAプラットフォーム市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：感染症ワクチン、がんワクチン - 世界のmRNAプラットフォームのタイプ別市場規模（2018年-2023年） - 世界のmRNAプラットフォームのタイプ別市場規模（2024年-2029年） ・用途別セグメント：感染症、がん - 世界のmRNAプラットフォームの用途別市場規模（2018年-2023年） - 世界のmRNAプラットフォームの用途別市場規模（2024年-2029年） ・mRNAプラットフォームの地域別市場規模 - 北米のmRNAプラットフォーム市場規模（2018年-2029年） - アメリカのmRNAプラットフォーム市場規模（2018年-2029年） - ヨーロッパのmRNAプラットフォーム市場規模（2018年-2029年） - アジア太平洋のmRNAプラットフォーム市場規模（2018年-2029年） - 中国のmRNAプラットフォーム市場規模（2018年-2029年） - 日本のmRNAプラットフォーム市場規模（2018年-2029年） - 韓国のmRNAプラットフォーム市場規模（2018年-2029年） - インドのmRNAプラットフォーム市場規模（2018年-2029年） - オーストラリアのmRNAプラットフォーム市場規模（2018年-2029年） - 中南米のmRNAプラットフォーム市場規模（2018年-2029年） - 中東・アフリカのmRNAプラットフォーム市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Arcturus Therapeutic、Argos Therapeutics、BioNTec、CureVac、Etherna、Ethris、GlaxoSmithKline、Pfizer、Translate Bio ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global mRNA Platform market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for mRNA Platform is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for mRNA Platform is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for mRNA Platform in Infectious Disease is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of mRNA Platform include Arcturus Therapeutic, Argos Therapeutics, BioNTec, CureVac, Etherna, Ethris, GlaxoSmithKline, Pfizer and Translate Bio, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for mRNA Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Platform.
The mRNA Platform market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global mRNA Platform market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Platform companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Arcturus Therapeutic
Argos Therapeutics
BioNTec
CureVac
Etherna
Ethris
GlaxoSmithKline
Pfizer
Translate Bio
Segment by Type
Infectious Disease Vaccines
Cancer Vaccines
Segment by Application
Infectious Disease
Cancer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Platform Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Infectious Disease Vaccines
1.2.3 Cancer Vaccines
1.3 Market by Application
1.3.1 Global mRNA Platform Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Infectious Disease
1.3.3 Cancer
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Platform Market Perspective (2018-2029)
2.2 mRNA Platform Growth Trends by Region
2.2.1 Global mRNA Platform Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 mRNA Platform Historic Market Size by Region (2018-2023)
2.2.3 mRNA Platform Forecasted Market Size by Region (2024-2029)
2.3 mRNA Platform Market Dynamics
2.3.1 mRNA Platform Industry Trends
2.3.2 mRNA Platform Market Drivers
2.3.3 mRNA Platform Market Challenges
2.3.4 mRNA Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Platform Players by Revenue
3.1.1 Global Top mRNA Platform Players by Revenue (2018-2023)
3.1.2 Global mRNA Platform Revenue Market Share by Players (2018-2023)
3.2 Global mRNA Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by mRNA Platform Revenue
3.4 Global mRNA Platform Market Concentration Ratio
3.4.1 Global mRNA Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Platform Revenue in 2022
3.5 mRNA Platform Key Players Head office and Area Served
3.6 Key Players mRNA Platform Product Solution and Service
3.7 Date of Enter into mRNA Platform Market
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Platform Breakdown Data by Type
4.1 Global mRNA Platform Historic Market Size by Type (2018-2023)
4.2 Global mRNA Platform Forecasted Market Size by Type (2024-2029)
5 mRNA Platform Breakdown Data by Application
5.1 Global mRNA Platform Historic Market Size by Application (2018-2023)
5.2 Global mRNA Platform Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America mRNA Platform Market Size (2018-2029)
6.2 North America mRNA Platform Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America mRNA Platform Market Size by Country (2018-2023)
6.4 North America mRNA Platform Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe mRNA Platform Market Size (2018-2029)
7.2 Europe mRNA Platform Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe mRNA Platform Market Size by Country (2018-2023)
7.4 Europe mRNA Platform Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific mRNA Platform Market Size (2018-2029)
8.2 Asia-Pacific mRNA Platform Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific mRNA Platform Market Size by Region (2018-2023)
8.4 Asia-Pacific mRNA Platform Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America mRNA Platform Market Size (2018-2029)
9.2 Latin America mRNA Platform Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America mRNA Platform Market Size by Country (2018-2023)
9.4 Latin America mRNA Platform Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Platform Market Size (2018-2029)
10.2 Middle East & Africa mRNA Platform Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa mRNA Platform Market Size by Country (2018-2023)
10.4 Middle East & Africa mRNA Platform Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Arcturus Therapeutic
11.1.1 Arcturus Therapeutic Company Detail
11.1.2 Arcturus Therapeutic Business Overview
11.1.3 Arcturus Therapeutic mRNA Platform Introduction
11.1.4 Arcturus Therapeutic Revenue in mRNA Platform Business (2018-2023)
11.1.5 Arcturus Therapeutic Recent Development
11.2 Argos Therapeutics
11.2.1 Argos Therapeutics Company Detail
11.2.2 Argos Therapeutics Business Overview
11.2.3 Argos Therapeutics mRNA Platform Introduction
11.2.4 Argos Therapeutics Revenue in mRNA Platform Business (2018-2023)
11.2.5 Argos Therapeutics Recent Development
11.3 BioNTec
11.3.1 BioNTec Company Detail
11.3.2 BioNTec Business Overview
11.3.3 BioNTec mRNA Platform Introduction
11.3.4 BioNTec Revenue in mRNA Platform Business (2018-2023)
11.3.5 BioNTec Recent Development
11.4 CureVac
11.4.1 CureVac Company Detail
11.4.2 CureVac Business Overview
11.4.3 CureVac mRNA Platform Introduction
11.4.4 CureVac Revenue in mRNA Platform Business (2018-2023)
11.4.5 CureVac Recent Development
11.5 Etherna
11.5.1 Etherna Company Detail
11.5.2 Etherna Business Overview
11.5.3 Etherna mRNA Platform Introduction
11.5.4 Etherna Revenue in mRNA Platform Business (2018-2023)
11.5.5 Etherna Recent Development
11.6 Ethris
11.6.1 Ethris Company Detail
11.6.2 Ethris Business Overview
11.6.3 Ethris mRNA Platform Introduction
11.6.4 Ethris Revenue in mRNA Platform Business (2018-2023)
11.6.5 Ethris Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline mRNA Platform Introduction
11.7.4 GlaxoSmithKline Revenue in mRNA Platform Business (2018-2023)
11.7.5 GlaxoSmithKline Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer mRNA Platform Introduction
11.8.4 Pfizer Revenue in mRNA Platform Business (2018-2023)
11.8.5 Pfizer Recent Development
11.9 Translate Bio
11.9.1 Translate Bio Company Detail
11.9.2 Translate Bio Business Overview
11.9.3 Translate Bio mRNA Platform Introduction
11.9.4 Translate Bio Revenue in mRNA Platform Business (2018-2023)
11.9.5 Translate Bio Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details